Company intelligence / Profile preview
Zocular
Bellaire, Texas, USA
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Zocular has developed several commercial eye care products using its proprietary Zokrex platform, which leverages activated okra-based polysaccharides to address ocular surface inflammation and biofilm. Clinical results for its ZEST (Zocular Eyelid System Treatment) procedure show significant improvements in tear breakup time (TBUT) and OSDI scores, along with reductions in inflammatory markers like MMP-9 and Demodex mite counts.
- Therapeutic areas
- OphthalmologyDermatology
- Modalities
- Botanical-based formulationPolysaccharidesMicellesDevice
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
NovaBay Pharmaceuticals
Beyond the preview
Go deeper on Zocular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zocular.